Medico Remedies

68
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE630Y01024
  • NSEID: MEDICO
  • BSEID: 540937
INR
48.04
-0.82 (-1.68%)
BSENSE

Aug 05, 11:08 AM

BSE+NSE Vol: 60.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024

Compare Profit and Loss Results of Medico Remedies
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
0.00
150.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
0.00
150.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
0.00
-5.00
0%
Raw Materials Consumed
113.00
0.00
113.00
0%
Power & Fuel Cost
2.00
0.00
2.00
0%
Employee Cost
6.00
0.00
6.00
0%
Operating Expenses
7.00
0.00
7.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
0.00
6.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
0.00
135.00
0%
Operating Profit (PBDIT) excl Other Income
15.00
0.00
15.00
0%
Other Income
2.00
0.00
2.00
0%
Operating Profit (PBDIT)
17.00
0.00
17.00
0%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
16.00
0.00
16.00
0%
Depreciation
3.00
0.00
3.00
0%
Profit Before Taxation & Exceptional Items
13.00
0.00
13.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
0.00
13.00
0%
Provision for Tax
3.00
0.00
3.00
0%
Profit After Tax
10.00
0.00
10.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
-7.00
39.00
557.14%
Profit Available for appropriations
42.00
-7.00
49.00
700.00%
Appropriations
42.00
-7.00
49.00
700.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
-0.08
1.30
1,625.00%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024

Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024